U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX390234: GSM1287867: U343 RNASeq miR137 transfection Rep1; Homo sapiens; RNA-Seq
1 ILLUMINA (Illumina Genome Analyzer IIx) run: 64.9M spots, 2.3G bases, 1.4Gb downloads

Submitted by: Gene Expression Omnibus (GEO)
Study: Genomic analyses reveal miR-137 broad impact on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells
show Abstracthide Abstract
miR-137 plays critical roles in the nervous system and tumor development. An increase in its expression is required for neuronal differentiation while its reduction is implicated in gliomagenesis. To evaluate the potential of miR-137 in glioblastoma therapy, we conducted genome-wide target mapping in glioblastoma cells by measuring levels of associations between PABP and mRNAs in cells transfected with miR-137 mimics vs. controls via RIPSeq. Impact on mRNA levels was also measured by RNASeq. By combining the results of both experimental approaches, 1468 genes were determined to be negatively impacted by miR-137; among them, 595 (40%) contain miR-137 predicted sites. The most relevant targets include oncogenic proteins and players in neurogenesis like c-KIT, YBX1, AKT2, CDC42, CDK6 and TGFß2. Interestingly, we observed that several identified miR-137 targets are also predicted to be regulated by miR-124, miR-128 and miR-7, which are equally implicated in neuronal differentiation and gliomagenesis. We suggest that the concomitant increase of these four miRNAs in neuronal stem cells or their repression in tumor cells could produce a robust regulatory effect with major consequences to neuronal differentiation and tumorigenesis. Overall design: Identification of genes affected by miR137 transfection via RIP-Seq and RNA-Seq in U251 and U343 cells
Sample: U343 RNASeq miR137 transfection Rep1
SAMN02440313 • SRS513760 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: Illumina Genome Analyzer IIx
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: For RNAseq experiments, cells were harvested after 48 hours for total RNA extraction using TRIzol. For RIPSeq, cell extracts were prepared from U251 and U343 transfected cells (miR-137 and control mimics) in polysomal lysis buffer, diluted in NT2 buffer and incubated for 3 hours with protein A-sepharose 4 Fast flow from GE conjugated with a mix of PABP antibodies. Beads were washed in NT2 buffer five times and subsequently digested with Proteinase K. RNA was extracted with phenol-chloroform, precipitated with isopropanol and kept at -80 degrees Celsius until usage. Total RNA was purified from control and miR-137 transfected cells with Trizol. Total RNA and RIP samples were depleted of 28S, 18S, 5.8S and 5S rRNA using RiboZero rRNA removal kit from Epicentre as per manufacters instructions. The rRNA depleted samples from U251 cells (16μl) were then mixed with 1μL random hexamers (500ng) and 1μL 10X MMLV Buffer, heated to 65oC for 2 minutes and placed on ice. To this mixture was added 2.5mM DTT, 0.5 mM dNTPs, 40 units of Riboguard and 50 units of EpiScript RT. First strand cDNA was then synthesized by incubation for 10 minutes at 25oC, 30 minutes at 42oC and 15 minutes at 70oC, then held at 4oC in a thermocycler with a heated lid. Second strand cDNA was synthesized by addition of 30 mM Tris pH 7.5, 5 mM MgCl2, 5 mM DTT, 0.3 mM each dNTP, 2.5 units of E. coli RNase H and 20 units of E. coli DNA polymerase I. The mixtures were then incubated for one hour at 16oC, followed by 15 minutes at 80oC. The reactions were then purified using Zymo DNA Clean kit and the samples were eluted with 16μL of nuclease-free water. The double-stranded cDNA was then fragmented and tagged using the Nextera DNA library kit from Epicentre as per the protocol supplied by the manufacturer and PCR amplified for 9 cycles. The samples were purified using Zymo DNA Clean kit and quantitated by using a bioanalyzer and Qubit methods, then sequenced on an Illumina GAIIx instrument for 36 cycles. After Ribo-Zero treating the RNA samples from the U343 cells, 50 ng were converted into double-stranded cDNA using the TotalScript cDNA kit as per the supplied protocol and purified using the Zymo DNA Clean and Concentrator kit. The cDNA was then tagmented and amplified using the Nextera DNA sample prep kit and purified using the Zymo DNA clean kit. The samples were quantitated by bioanalyzer and Qubit methods, then sequenced on an Illumina GAIIx instrument for 36 cycles.
Experiment attributes:
GEO Accession: GSM1287867
Links:
External link:
Runs: 1 run, 64.9M spots, 2.3G bases, 1.4Gb
Run# of Spots# of BasesSizePublished
SRR104763264,855,0872.3G1.4Gb2014-02-11

ID:
560936

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...